SA
Sign upLog In

Novo Nordisk A/S Common Stock (NVO)

Income Tax Expense

kr 32.31B

TTM · Period ending: · DKK

NVO logo

NVO Income Tax Expense

Latest reportedkr 32.31B DKK
NVO TTM Income Tax · DKK (kr 0.00 → kr 32.31B)
High-resolution chart · PNG

NVO income tax expense history

Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.

Novo Nordisk A/S Common Stock Income Tax Expense — Trailing twelve months (TTM) (DKK)
Period endingIncome Tax Expense (DKK)
32,306,000,000
33,722,000,000
28,106,000,000
28,139,000,000
29,711,000,000
27,691,000,000
26,203,000,000
24,533,000,000
23,035,000,000
22,579,000,000
20,991,000,000
18,058,000,000
16,100,000,000
14,751,000,000
13,537,000,000
13,034,000,000
12,400,000,000
11,717,000,000
11,323,000,000
11,786,000,000
11,186,000,000
11,183,000,000
10,992,000,000
10,670,000,000
10,190,000,000
9,949,000,000
9,602,000,000
9,113,000,000
9,301,000,000
8,906,000,000
8,987,000,000
9,432,000,000
10,023,000,000
10,560,000,000
10,550,000,000
10,475,000,000
10,281,000,000
10,223,000,000
9,873,000,000
9,686,000,000
8,941,000,000
8,512,000,000
8,623,000,000
8,390,000,000
8,591,000,000
8,381,000,000
7,615,000,000
7,529,000,000
7,459,000,000
7,411,000,000
7,355,000,000
7,315,000,000
7,123,000,000
6,773,000,000
6,379,000,000
5,804,000,000
5,367,000,000
5,004,000,000
4,828,000,000
4,465,000,000
4,281,000,000
4,107,000,000
3,883,000,000
3,793,000,000
3,574,000,000
3,407,000,000
3,220,000,000
3,301,970,000
3,291,970,000
3,180,955,000
3,062,955,000
2,687,911,200
2,519,691,200
2,480,321,200
2,456,458,200
2,763,527,000
2,848,526,000
2,853,124,000
2,706,104,000
2,507,562,000
2,412,515,000
2,323,828,000
2,364,200,000
2,560,922,000
2,507,598,000
2,482,795,000
2,450,959,000
1,769,784,000
1,159,376,000
525,653,000
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.